Hypothesis: Use of the vacuum assisted closure device (VAC) for securing split-thickness skin grafts (STSGs) is associated with improved wound outcomes compared with bolster dressings.
ster dressing (n=27). The VAC group required significantly fewer repeated STSGs (1 [3%] vs 5 [19%] ; P=.04). Two additional graft failures occurred in the no-VAC group, but repeated STSGs were refused by these patients. No difference was seen between the groups in age, percentage of graft take, or hospital length of stay. The no-VAC group had significantly larger grafts (mean±SD, 984 ± 996 vs 386 ± 573 cm 2 ; P = .006). The patients requiring repeated STSGs (n = 6) did not have significantly larger grafts than those not requiring repeated STSGs (mean±SD, 617±717 vs 658±857 cm 2 ; P=.62). No dressing-associated complications occurred in the VAC group.
Conclusions:
The VAC provides a safe and effective method for securing STSGs and is associated with improved graft survival as measured by a reduction in number of repeated STSGs.
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S
OFT TISSUE coverage for complicated wounds remains a difficultmanagementproblemfor patients sustaining traumatic injuries and burns. Several methodsachievewoundcoverage,andplacement of split-thickness skin grafts (STSGs) isoftenrequired.Theliteratureisrepletewith recommendations for securing STSGs to wounds, [1] [2] [3] [4] [5] [6] but it has little about the use of the vacuum assisted closure device (VAC; KineticConcepts,Inc,SanAntonio,Tex)and its impact on graft outcome. 7, 8 The VAC is a modified dressing consisting of a sponge and suction tubing that is secured to the wound with an occlusive dressing. Use of the suction tubing creates a continuous negative-pressure dressing. This device has been associated with accelerated development of granulation tissue, 9 ,10 earlier reepithelialization of wounds, 11 and faster healing of burn wounds and has been used to manage very complex wounds successfully. 12, 13 The VAC has been used in a variety of clinical situations, including securing STSGs to the cranium, where it has met with success in this notoriously difficult region. 14 We evaluated the safety and efficacy of the VAC at securing skin grafts in patients who had sustained traumatic or thermal tissue loss.
RESULTS
Sixty-one patients underwent STSG placement; grafts were managed with bolster dressings in 27 and with the VAC in 34 (56% VAC use rate). The STSGs were placed for the following indications: burn (n = 32 [52%]), soft tissue loss (n=27 [44%]), and fasciotomy-site coverage (n=2 [3%]).
We saw no significant difference in age, total hospital length of stay, post-STSG length of stay, or day of postoperative wound evaluation between the groups. There were significantly fewer repeated STSGs required in the VAC group (3% vs 19%). The mean graft size was larger in the no-VAC group ( Table 1) .
When comparing patients who required repeated skin grafts with those who did not, we found no significant difference in age, graft size, or day of postoperative wound evaluation. The patients un- dergoing repeated STSGs had significantly longer post-STSG and overall hospital lengths of stay ( Table 2) . Table 3 demonstrates that most patients with graft failure had sustained burns. The graft failures were of small to moderate size (50-800 cm 2 ), and most cases involved a heavily contoured or poorly vascularized surface.
PAPER
In addition to the 6 patients undergoing repeated STSG placement, 2 additional patients in the no-VAC group had graft failure, but both refused repeated skin grafts. These 2 patients were excluded from the analysis of the repeated STSG group. No dressing-related complications were identified in the VAC group. The distribution of graft failure, based on indication for graft placement and dressing type, is shown in Table 4 .
COMMENT
Our data suggest that a negative-pressure dressing over an STSG site may improve overall graft survival, as measured by fewer episodes of repeated grafting. Several pos- 
PATIENTS AND METHODS
We reviewed consecutive STSG placements at a level I trauma center during an 18-month period. We identified all patients on the trauma surgery service who required STSGs during the study period by using registry data, and we reviewed their medical charts. The STSGs were all harvested using a Zimmer dermatome (Zimmer, Inc, Warsaw, Ind) to obtain a 0.03-cm (0.012-in) STSG that was meshed.
In the no-VAC group, the STSG was secured to the recipient site using circumferential staples followed by a fine mesh gauze covering that was stapled circumferentially to the site. The entire site was bolstered with bulky cotton gauze dressing, wrapped with a cotton gauze bandage, and kept moist with 5% mafenide (Sulfamylon) solution. 15 Based on the location of the injury, bed rest, a sling, or a splint was used to keep the area immobilized.
In the VAC group, the STSG was secured to the recipient site using circumferential staples, followed by placement of a nonadherent dressing (Adaptic; Johnson & Johnson Medical, Inc, Arlington, Tex). The VAC sponge was cut to match the contour of the wound and was secured to the surrounding skin using benzoin spray and an adherent, occlusive dressing (Ioban; 3M, St Paul, Minn) (Figures 1, 2, and  3) . The VAC was placed to continuous −125-mm Hg suction. Continuous negative pressure was ensured by clamping the VAC tubing and assessing for an air leak within the dressing. If an air leak was present, the leaking site was identified and repaired with a strip of the adherent dressing. The VAC dressing was left decompressed and clamped while the patient was transported to the recovery room and back to the hospital room. Once in the hospital room, the wound VAC was returned to suction until the dressing was removed. During the postoperative period, attempts were made to keep the affected area immobilized.
The dressings in both groups were left in place until the fourth postoperative day unless signs suggestive of wound infection developed, at which point the dressing was removed and the wound was evaluated.
We reviewed medical charts for demographic data, the indication for skin graft, the size of the skin graft (obtained from the dictated operative report), an estimate of graft take based on physician progress notes, the need for repeated skin grafting to the same site, the size and location of the repeated graft, hospital length of stay, and the post-STSG hospital length of stay. We compared the group of patients treated with the VAC to the group treated without the VAC using a 1-way analysis of variance for continuous data and the Fisher exact test for dichotomous data. Significance was accepted at PϽ.05.
tulates suggest why negative-pressure dressings may improve graft survival. 9, 12 First, an important aspect to successful graft take is maintaining good apposition between the graft and the wound surface. By design, continuous negative-pressure dressings provide a uniform distribution of pressure and apposition between the graft and the wound bed in most cases, even if the surface contour is irregular. 9, 14 This becomes particularly important for patients with traumatic injuries necessitating skin grafting, as these grafts are often in irregularly contoured regions such as the hand, wrist, and ankle. Second, accumulation of hematoma or seroma under the graft contributes to graft loss. The negative-pressure dressing provides continuous removal of wound fluid, which prevents the accumulation of hematoma or seroma while maintaining graftto-wound apposition. 7, 9 Third, desiccation is detrimental to wound healing 16 and is reduced with the occlusive nature of the VAC dressing, in which a moist environment is maintained. Last, infection contributes to graft loss. The VAC has been associated with lower bacterial counts at wound sites, 10 and this reduction in the local bacterial flora may enhance graft survival.
Shear stress to the grafted site after STSG placement is a risk regardless of the method used to secure the graft. We kept the VAC decompressed and clamped from the operating room until the patient reached the hospital room, and we tried to minimize episodes of suction release. This effort was intended to reduce shear injury potentially associated with loss of suction to the VAC and, in this study, graft loss due to suction loss never occurred. Another important aspect to reducing shear injury is limiting the mobility of the graft on the wound bed. The VAC device provides graft stabilization and may reduce the chance for shear injury to the graft from movement.
The grafts were significantly larger in the no-VAC group, and this may lead to the conclusion that the larger wounds contributed to the poorer graft survival in the no-VAC group. However, this contention has not been supported by the literature. Also, despite the discrepancy in graft size between the groups, comparison between the subset of patients who had graft failure culminating in repeated grafting and those who did not showed no significant difference in age, graft size, or day to postoperative evaluation. In fact, when the 6 repeated grafts were evaluated, the repeated grafts were of small to moderate size in highly contoured or poorly vascularized regions.
This study has the weakness of being a retrospective review, and retrospective evaluation of the percentage of graft take is difficult to determine, as it is an estimation that is wrought with observer bias at best. Therefore, we chose to emphasize what we consider to be clinically more important, ie, that the patients who were treated with the VAC required fewer return trips to the operating room for a second graft to the same site (3% vs 19%). We deemed the need for repeated grafting to be an easily identifiable event that would suggest the graft loss incurred by the patient was clinically important.
Not surprisingly, patients who required repeated grafting had longer post-STSG and overall hospital lengths of stay, due in part to the time required for repeated skin grafting. At most institutions, the VAC is likely to be more costly than bolster-type dressings. However, reducing the need for repeated grafting should eliminate repeated surgical expenses, reduce the extra hospital days incurred by graft loss, and potentially offset the cost of the VAC.
CONCLUSIONS
We reviewed a larger number of patients than have been previously described, and our results continue to suggest that the VAC is an excellent alternative for securing skin grafts to the wound bed and achieving better graft outcome. From our observations, we support using negativepressure dressings over skin graft sites and believe that, to better quantify outcome measures, further study of this device in a prospective, randomized fashion is warranted. 
DISCUSSION
Gail T. Tominaga, MD, Honolulu, Hawaii: Bolster dressings are a classic method of graft fixation that has been successful in the majority of patients. However, inadequate graft bed, hematoma, fluid collection, movement, infection, and technical error can contribute to graft loss. Attempts at grafting on mobile surfaces or complex contoured surfaces are more problematic. The authors describe a technique that immobilizes the graft, eliminates fluid collections, and decreases wound bacterial counts, resulting in enhanced healing. The authors retrospectively reviewed 61 patients undergoing STSG due to traumatic or thermal tissue loss. Thirty-four patients were managed with the vacuum assisted closure device (VAC) and 27 patients with bolster dressings.
There was no significant difference in age, total hospital length of stay, post-STSG length of stay, or day of postoperative wound evaluation between the 2 groups. The 2 groups did differ on 2 parameters: (1) graft size (the no-VAC group had a larger mean graft size) and (2) need for repeat skin grafting (the no-VAC group had 5 out of 27 patients regrafted). The VAC group had 1 out of 34 patients regrafted. Four of the 6 patients with graft failures had sustained burns, and all were in heavily contaminated or heavily contoured or poorly vascularized surfaces. 
